REINALDO RAMON PAMPLONA GRAS-rekin lankidetzan egindako argitalpenak (10)

2024

  1. Cerebrospinal fluid neutral lipids predict progression from mild cognitive impairment to Alzheimer’s disease

    GeroScience, Vol. 46, Núm. 1, pp. 683-696

  2. Human lifespan and sex-specific patterns of resilience to disease: a retrospective population-wide cohort study

    BMC Medicine, Vol. 22, Núm. 1

2023

  1. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134

  2. Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1728-1738

  3. Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1887-1916

2022

  1. Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease

    Alzheimer's Research and Therapy, Vol. 14, Núm. 1

2021

  1. Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer's disease

    Sleep, Vol. 44, Núm. 2

  2. Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression

    Brain Communications, Vol. 3, Núm. 3

2017

  1. Region-specific vulnerability to lipid peroxidation and evidence of neuronal mechanisms for polyunsaturated fatty acid biosynthesis in the healthy adult human central nervous system

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1862, Núm. 5, pp. 485-495

2009

  1. Cell death and learning impairment in mice caused by in vitro modified pro-NGF can be related to its increased oxidative modifications in Alzheimer disease

    American Journal of Pathology, Vol. 175, Núm. 6, pp. 2574-2585